Invitation to the presentation of Calliditas´s interim report January - June 2024

Rhea-AI Summary

Calliditas Therapeutics (CALT) has announced the upcoming release of its interim report for Q2 2024 (April - June) on Tuesday, August 13, 2024, at 07:00 a.m. CET. The report will be available in both Swedish and English. Following the release, the company will host a combined audio cast and telephone conference at 14:30 p.m. CET on the same day.

The presentation will feature CEO Renée Aguiar-Lucander, CFO Fredrik Johansson, CMO Richard Philipson, and President North America Maria Törnsén. Participants will have the opportunity to ask questions during the event, which will be conducted in English. Interested parties can join via webcast or conference call, with registration required for the latter.

STOCKHOLM, Aug. 5, 2024 /PRNewswire/ -- Calliditas's interim report for the second quarter, April - June 2024 will be published in Swedish and English on Tuesday 13 August 2024 at 07.00 a.m. CET.

A combined audio cast and telephone conference with the opportunity to ask questions will be held at 14.30 p.m. CET on the same day, with CEO Renée Aguiar-Lucander and CFO Fredrik Johansson, CMO Richard Philipson and President North America Maria Törnsén.

The presentation will be given in English.

Link to the webcast: 

https://ir.financialhearings.com/calliditas-therapeutics-q2-report-2024

To participate via conference call please register via this link:

https://conference.financialhearings.com/teleconference/?id=50049712

After registration, you will receive a phone number and a conference ID to log in to the conference call. Via the telephone conference, there is an opportunity to ask oral questions.

For further information, please contact:
Åsa Hillsten, Head of IR & Sustainability, Calliditas
Tel.: +46 76 403 35 43, Email: asa.hillsten@calliditas.com

The information was sent for publication, through the agency of the contact persons set out above, on August 5, 2024 at 7:00 a.m. CET.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/calliditas-therapeutics/r/invitation-to-the-presentation-of-calliditas-s-interim-report-january---june-2024,c4019260

The following files are available for download:

https://mb.cision.com/Main/16574/4019260/2928380.pdf

Invitation to the presentation of Calliditas_Q2 2024 ENG

 

View original content:https://www.prnewswire.com/news-releases/invitation-to-the-presentation-of-calliditass-interim-report-january--june-2024-302214085.html

SOURCE Calliditas Therapeutics

FAQ

When will Calliditas Therapeutics (CALT) release its Q2 2024 interim report?

Calliditas Therapeutics will release its Q2 2024 interim report on Tuesday, August 13, 2024, at 07:00 a.m. CET.

Who will present Calliditas Therapeutics (CALT) Q2 2024 results?

The Q2 2024 results will be presented by CEO Renée Aguiar-Lucander, CFO Fredrik Johansson, CMO Richard Philipson, and President North America Maria Törnsén.

How can I participate in Calliditas Therapeutics (CALT) Q2 2024 earnings call?

You can participate via webcast or conference call. The webcast link is provided in the press release, and for the conference call, registration is required through a separate link.

What time is Calliditas Therapeutics (CALT) Q2 2024 earnings call?

The earnings call for Calliditas Therapeutics Q2 2024 results is scheduled for Tuesday, August 13, 2024, at 14:30 p.m. CET.